Primary Angiitis of the Central Nervous System

Standard

Primary Angiitis of the Central Nervous System : New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid. / Deb-Chatterji, Milani; Schuster, Simon; Haeussler, Vivien; Gerloff, Christian; Thomalla, Götz; Magnus, Tim.

in: FRONT NEUROL, Jahrgang 10, 06.06.2019, S. 568.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

APA

Vancouver

Bibtex

@article{67971cd253be4de189766d44a2e16340,
title = "Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid",
abstract = "Primary angiitis of the central nervous system (PACNS) is an inflammatory brain disease affecting the medium and small vessels of the CNS. Although recent data of patients with PACNS have advanced the understanding of the disease, the diagnosis remains challenging. Clinical presentation of PACNS is broad and unspecific and the majority of the diagnostic approaches are hallmarked by a low specificity. Thus, PACNS is commonly misdiagnosed. In addition, due to its potential aggressive course which may be altered by an adequate immunosuppressive treatment, delineation from other vasculopathies and PACNS mimics is crucial. New diagnostic tools and biomarkers which increase specificity and facilitate the diagnosis for patients with suspected PACNS are highly desirable. This short review summarizes the current procedures within the diagnostic process and aims to illustrate its difficulties and challenges. Furthermore, it highlights emerging biomarkers in the cerebrospinal fluid and peripheral venous blood as well as novel potential imaging tools that may corroborate the diagnosis. With new imaging techniques and a panel of biomarkers the certainty of the diagnosis may be increased and diagnostic processes more accelerated in the future.",
author = "Milani Deb-Chatterji and Simon Schuster and Vivien Haeussler and Christian Gerloff and G{\"o}tz Thomalla and Tim Magnus",
year = "2019",
month = jun,
day = "6",
doi = "10.3389/fneur.2019.00568",
language = "English",
volume = "10",
pages = "568",
journal = "FRONT NEUROL",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Primary Angiitis of the Central Nervous System

T2 - New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid

AU - Deb-Chatterji, Milani

AU - Schuster, Simon

AU - Haeussler, Vivien

AU - Gerloff, Christian

AU - Thomalla, Götz

AU - Magnus, Tim

PY - 2019/6/6

Y1 - 2019/6/6

N2 - Primary angiitis of the central nervous system (PACNS) is an inflammatory brain disease affecting the medium and small vessels of the CNS. Although recent data of patients with PACNS have advanced the understanding of the disease, the diagnosis remains challenging. Clinical presentation of PACNS is broad and unspecific and the majority of the diagnostic approaches are hallmarked by a low specificity. Thus, PACNS is commonly misdiagnosed. In addition, due to its potential aggressive course which may be altered by an adequate immunosuppressive treatment, delineation from other vasculopathies and PACNS mimics is crucial. New diagnostic tools and biomarkers which increase specificity and facilitate the diagnosis for patients with suspected PACNS are highly desirable. This short review summarizes the current procedures within the diagnostic process and aims to illustrate its difficulties and challenges. Furthermore, it highlights emerging biomarkers in the cerebrospinal fluid and peripheral venous blood as well as novel potential imaging tools that may corroborate the diagnosis. With new imaging techniques and a panel of biomarkers the certainty of the diagnosis may be increased and diagnostic processes more accelerated in the future.

AB - Primary angiitis of the central nervous system (PACNS) is an inflammatory brain disease affecting the medium and small vessels of the CNS. Although recent data of patients with PACNS have advanced the understanding of the disease, the diagnosis remains challenging. Clinical presentation of PACNS is broad and unspecific and the majority of the diagnostic approaches are hallmarked by a low specificity. Thus, PACNS is commonly misdiagnosed. In addition, due to its potential aggressive course which may be altered by an adequate immunosuppressive treatment, delineation from other vasculopathies and PACNS mimics is crucial. New diagnostic tools and biomarkers which increase specificity and facilitate the diagnosis for patients with suspected PACNS are highly desirable. This short review summarizes the current procedures within the diagnostic process and aims to illustrate its difficulties and challenges. Furthermore, it highlights emerging biomarkers in the cerebrospinal fluid and peripheral venous blood as well as novel potential imaging tools that may corroborate the diagnosis. With new imaging techniques and a panel of biomarkers the certainty of the diagnosis may be increased and diagnostic processes more accelerated in the future.

U2 - 10.3389/fneur.2019.00568

DO - 10.3389/fneur.2019.00568

M3 - SCORING: Review article

C2 - 31244749

VL - 10

SP - 568

JO - FRONT NEUROL

JF - FRONT NEUROL

SN - 1664-2295

ER -